These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 1676773
1. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases]. Miagkova LP, Grebenev AL, Kkhorshed AM. Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773 [No Abstract] [Full Text] [Related]
2. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases]. Grebnev AL, Miagkova LP, Kkhorshed AM. Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772 [No Abstract] [Full Text] [Related]
3. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders]. Tani N, Miwa T. Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482 [No Abstract] [Full Text] [Related]
12. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH. Dubin SA, Silverstein PI, Wakefield ML, Jense HG. Anesth Analg; 1989 Nov 01; 69(5):680-3. PubMed ID: 2572186 [No Abstract] [Full Text] [Related]
13. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases. Langtry HD, Grant SM, Goa KL. Drugs; 1989 Oct 01; 38(4):551-90. PubMed ID: 2573505 [Abstract] [Full Text] [Related]
15. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease. Kedziora-Kornatowska K, Tkaczewski W, Blaszczyk J, Buczynski A, Chojnacki J, Kedziora J. Hepatogastroenterology; 1998 Oct 01; 45(19):276-80. PubMed ID: 9496526 [Abstract] [Full Text] [Related]
17. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease. Thomson AB. Hepatogastroenterology; 1990 Jul 01; 37 Suppl 1():18-28. PubMed ID: 1976583 [Abstract] [Full Text] [Related]
18. [Effect of M-cholinolytics and histamine H2 receptor blockaders on the acid-peptide factor in patients with peptic ulcer]. Masevich TsG, Shastina NN. Klin Med (Mosk); 1987 Oct 01; 65(10):73-6. PubMed ID: 2892966 [No Abstract] [Full Text] [Related]
19. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer]. Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA. Ter Arkh; 1989 Oct 01; 61(8):59-62. PubMed ID: 2573963 [Abstract] [Full Text] [Related]